Aequus Pharmaceuticals (AQS) Stock Chart & Stock Price History C$0.0050 0.00 (-37.50%) As of 04/25/2025 Add Compare Share Share Chart Stock AnalysisChartEarningsInsider TradesBuy This Stock Aequus Pharmaceuticals Stock Price Performance The Aequus Pharmaceuticals (AQS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 80.00%, with a year-to-date return of -50.00%. In the past month, the stock has remained steady at 0.00%, reflecting recent market activity. As of the latest close, Aequus Pharmaceuticals traded at C$0.01 with a market cap of C$663 thousand and volume of 100,000 shares. Five years ago, the stock traded at C$0.09, representing a 94.12% decrease over that period. At the time, it had a market cap of C$6.84 million and a volume of 1,250 shares. Receive AQS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aequus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance0.00%3 Month Performance0.00%Year-To-Date Performance-50.00%1 Year Performance-80.00%5 Year Performance-94.12% AQS Stock Chart for Friday, June, 13, 2025 AQS Chart by TradingView Aequus Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/12/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/11/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/10/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/09/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/06/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/05/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/04/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/03/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0006/02/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.00 Get the Latest News and Ratings for AQS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aequus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0005/29/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0005/28/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0005/27/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0005/26/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0005/23/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0005/22/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0005/21/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0005/20/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0005/19/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0005/16/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0005/15/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0005/14/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0005/13/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.0005/12/2025C$0.01C$0.01C$0.01C$0.01100,000 shsC$663,000.00 Related Companies ENTG Stock Chart DHT.UN Stock Chart PWR Stock Chart BHC Stock Chart CRON Stock Chart GUD Stock Chart ACB Stock Chart Receive AQS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aequus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:AQS) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aequus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aequus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AQS Stock Free AQS Stock Alerts